A comparison of the efficacy of low-volume versus high-volume injection of epiduralsteroids in the management of back pai

Not Applicable

Conditions: Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissueHealth Condition 2: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Recruitment & Eligibility

Inclusion Criteria

1. Adult patients (aged 25-50 Years), capable of providing consent and complying with the outcome

instruments

2. Single-level lumbar disc herniation diagnosed by MRI

3. Lower lumbar disc herniation diagnosed by MRI (L4/L5 or L5S1).

4. Signs and symptoms consistent with the nerve root irritation

5. Patients with lumbar radicular pain, irrespective of neurological signs.

6. Patients have refractory pain, even after treatment with NSAIDs, opioids, and/or physical

therapies for more than two weeks duration.

7. Failure after a minimum of 6 weeks of conservative treatment

Exclusion Criteria

Patientâ??s reluctance and lack of compliance, does not provide informed consent for the

study

2. Patients with previous back surgery at the affected segmental level and radiologically

proven facet syndrome

3. Multiple level lumbar disc herniation diagnosed by MRI

4. Patients with a severe motor deficit, segmental instability, spinal deformities.

5. Any systemic infection or local infection at the injection site

6. Patients presenting with cauda equina syndrome

7. Patients on anticoagulation therapy or having any bleeding disorder

8. Patients with congestive heart failure or uncontrolled blood sugars

9. Pregnant females or ongoing breastfeeding females

10. Patients with underlying malignancy

11. Patients are not excluded based on the duration of pain alone.

12. Patients who are allergic to any component of the medicine?

Primary Outcome Measures

Name	Time	Method
To compare the efficacy of low volume <br/ ><br>corticosteroid injections in the treatment of low <br/ ><br>back pain and radiculopathy associated with <br/ ><br>lumbar degenerative diseases with that of <br/ ><br>conventional high-volume injection.Timepoint: 1. Pre injection <br/ ><br>2. Post injection <br/ ><br>At 3 weeks, 6 weeks, and 3 months

Secondary Outcome Measures

Name	Time	Method
To compare the side effects, if any, of low-volume versus high-volume corticosteroid injections <br/ ><br>in the treatment of low back pain.Timepoint: During the injection and in the next 24 hours after the injection